Naoki Sakata So-Ichi Suenobu Munehiro Okano Satoshi Ueda Masatomo Kimura Tsukasa Takemura
10.1177/2036361318776185
Rare Tumors
2018 May 30;10:2036361318776185.
kasabach–merritt phenomenon sirolimus kaposiform hemangioendothelioma mammalian target of rapamycin molecular targeting drug
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/29872523/
Case Reports
PMC5977423
29872523
Impact of sirolimus treatment for refractory kaposiform hemangioendothelioma with exacerbation of the disease 10 years after initial diagnosis
2018